Study on the Appropriate Timing of Postoperative Adaptive Radiotherapy for High-Grade Glioma

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2021 May 6

PMID 33953610

Citations 1

Authors

Ying Cao

Du Tang

Yining Xiang

Li Men

Chao Liu

Qin Zhou

Jun Wu

Lei Huo

Tao Song

Ying Wang

Zhanzhan Li

Rui Wei

Liangfang Shen

Zhen Yang

Jidong Hong

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the appropriate timing of adaptive radiotherapy (ART) for high-grade glioma.

Methods: Ten patients with high-grade gliomas were selected and underwent CT/MRI (CT/MRI, CT/MRI, CT/MRI, and CT/MRI) scans before RT and during 10-, 20- and 30-fraction RT, and the corresponding RT plans (plan, plan, plan and plan) were made. The dose of the initial plan (plan) was projected to CT2 and CT3 using the image registration technique to obtain the projection plans (plan and plan) and by superimposing the doses to obtain the ART plans (plan and plan), respectively. The dosimetric differences in the target volume and organs at risk (OARs) were compared between the projection and adaptive plans. The tumor control probability (TCP) for the planning target volume (PTV) and normal tissue complication probability (NTCP) for the OARs were compared between the two adaptive plans.

Results: Compared with the projection plan, the D to the PTV of ART decreased, the conformity index (CI) to the PTV increased, and the D/D to the brainstem, optic chiasm and pituitary, as well as the V, V, V and V to the normal brain decreased. The D to the pituitary and optic chiasm as well as the V, V, V and V to the normal brain in plan were lower than those in plan, while the CI to the PTV was higher than that in plan. The TCP of the PTV in plan was higher than that in plan.

Conclusion: ART can improve the precision of target volume irradiation and reduce the irradiation dose to the OARs in high-grade glioma. The time point after 10 fractions of RT is appropriate for ART.

Citing Articles

Radiotherapy of High-Grade Gliomas: First Half of 2021 Update with Special Reference to Radiosensitization Studies.

Frosina G Int J Mol Sci. 2021; 22(16).

PMID: 34445646 PMC: 8396323. DOI: 10.3390/ijms22168942.

References

Paddick I . A simple scoring ratio to index the conformity of radiosurgical treatment plans. Technical note. J Neurosurg. 2001; 93 Suppl 3:219-22. DOI: 10.3171/jns.2000.93.supplement. View

Ruben J, Dally M, Bailey M, Smith R, McLean C, Fedele P . Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys. 2006; 65(2):499-508. DOI: 10.1016/j.ijrobp.2005.12.002. View

Burman C, Kutcher G, Emami B, Goitein M . Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991; 21(1):123-35. DOI: 10.1016/0360-3016(91)90172-z. View

Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L . Intensity-modulated radiotherapy for gliomas:dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue. Onco Targets Ther. 2016; 9:3545-54. PMC: 4914054. DOI: 10.2147/OTT.S100455. View

Tsien C, Brown D, Normolle D, Schipper M, Piert M, Junck L . Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res. 2011; 18(1):273-9. PMC: 3266840. DOI: 10.1158/1078-0432.CCR-11-2073. View

Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G . Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007; 356(15):1527-35. DOI: 10.1056/NEJMoa065901. View

Cabrera A, Kirkpatrick J, Fiveash J, Shih H, Koay E, Lutz S . Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2016; 6(4):217-225. DOI: 10.1016/j.prro.2016.03.007. View

Kutcher G, Burman C . Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989; 16(6):1623-30. DOI: 10.1016/0360-3016(89)90972-3. View

Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

10.

Kim T, Lim D . Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma. J Korean Med Sci. 2013; 28(8):1233-7. PMC: 3744714. DOI: 10.3346/jkms.2013.28.8.1233. View

11.

Stupp R, Mason W, van den Bent M, Weller M, Fisher B, Taphoorn M . Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-96. DOI: 10.1056/NEJMoa043330. View

12.

LYMAN J . Normal tissue complication probabilities: variable dose per fraction. Int J Radiat Oncol Biol Phys. 1992; 22(2):247-50. DOI: 10.1016/0360-3016(92)90040-o. View

13.

Niemierko A . Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997; 24(1):103-10. DOI: 10.1118/1.598063. View

14.

Yan D, Ziaja E, Jaffray D, Wong J, Brabbins D, Vicini F . The use of adaptive radiation therapy to reduce setup error: a prospective clinical study. Int J Radiat Oncol Biol Phys. 1998; 41(3):715-20. DOI: 10.1016/s0360-3016(97)00567-1. View

15.

Shukla D, Huilgol N, Trivedi N, Mekala C . T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomas. J Cancer Res Ther. 2007; 1(4):235-8. DOI: 10.4103/0973-1482.19601. View

16.

Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P . Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002; 20(8):2076-84. DOI: 10.1200/JCO.2002.08.121. View

17.

Mehta S, Gajjar S, Padgett K, Asher D, Stoyanova R, Ford J . Daily Tracking of Glioblastoma Resection Cavity, Cerebral Edema, and Tumor Volume with MRI-Guided Radiation Therapy. Cureus. 2018; 10(3):e2346. PMC: 5959724. DOI: 10.7759/cureus.2346. View

18.

Tsien C, Gomez-Hassan D, Ten Haken R, Tatro D, Junck L, Chenevert T . Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys. 2005; 62(2):328-32. DOI: 10.1016/j.ijrobp.2004.10.010. View

19.

MacDonald S, Ahmad S, Kachris S, Vogds B, DeRouen M, Gittleman A . Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison. J Appl Clin Med Phys. 2007; 8(2):47-60. PMC: 5722415. DOI: 10.1120/jacmp.v8i2.2423. View

20.

Olson J, Riedel E, DeAngelis L . Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000; 54(7):1442-8. DOI: 10.1212/wnl.54.7.1442. View